Parila, Ronnie D.

HRN: 27-61-14  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/08/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
04/08/2026
04/14/2026
IV
2.25g
Q8
HAP
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: